When muscle weakness develops, it can be hard to tell amyotrophic lateral sclerosis (ALS) and myasthenia gravis apart — even for doctors. Although these conditions both affect muscle function, their causes, treatments, and outcomes are quite different.
Understanding the differences and similarities between myasthenia gravis and ALS can help you prepare for appointments and better understand your diagnosis and treatment options. Here, we’ll discuss eight ways in which myasthenia gravis and ALS differ, as well as seven ways in which they’re the same.
ALS is a disease that causes motor neurons — nerve cells in the brain, brainstem, and spinal cord — to break down over time. This leads to worsening muscle weakness and atrophy (muscle loss).
ALS is a complex disease that doesn’t yet have a cure. However, current treatments can help to slow progression and relieve symptoms.
Myasthenia gravis is an autoimmune disease — a condition in which the body’s defense system mistakenly attacks itself. In myasthenia gravis, the immune system makes antibodies (special proteins) that attack different parts of the connection between nerves and muscles.
Myasthenia gravis antibodies target specific proteins, such as acetylcholine receptors (AChR), muscle-specific tyrosine kinase (MuSK), or low-density lipoprotein receptor-related protein 4 (LRP4). This disrupts nerve-to-muscle communication in different ways, leading to muscle weakness and fatigue.
Both ALS and myasthenia gravis are neurological disorders (conditions that affect the nervous system) that affect how muscles function. Having one of these diseases doesn’t necessarily increase your risk of developing the other. In fact, less than 1 percent of people with ALS also have myasthenia gravis.
ALS and myasthenia gravis have different causes, but they have several things in common. For example, both conditions affect muscle function and can have a significant impact on daily life.
Both ALS and myasthenia gravis can affect people of any age. But they tend to affect different age groups.
ALS is more common in older adults, typically developing after age 50. Myasthenia gravis is more common among females younger than 40 and males older than 60, according to the Muscular Dystrophy Association.
People with ALS or myasthenia gravis experience muscle weakness. This symptom can make routine tasks more difficult. Simple activities like climbing stairs, getting dressed, or preparing meals may become challenging.
In ALS, muscle weakness usually gets worse over time. Daily tasks may become more difficult. Myasthenia gravis symptoms tend to fluctuate and may improve with treatment.
People living with myasthenia gravis may find that they have more trouble with activities some days than others.
Both ALS and myasthenia gravis can cause dysphagia (difficulty swallowing) and dysarthria (difficulty speaking). These symptoms can affect how people communicate, making it hard to speak clearly. They can affect nutrition, making it harder to eat and drink.
As ALS and myasthenia gravis progress, they may cause breathing difficulties. However, the way in which breathing problems are treated differs.
In myasthenia gravis, flares can cause breathing problems if respiratory muscles become weak. Myasthenic crisis is a severe, life-threatening flare and may require noninvasive or invasive ventilation (breathing support) along with treatment for myasthenia gravis itself.
In ALS, respiratory muscle weakness tends to get worse over time. Oxygen therapy alone doesn’t correct breathing problems caused by weak muscles and may even be unsafe in some cases. Noninvasive or invasive ventilation can help support breathing and relieve symptoms.
Fatigue is a major symptom of both ALS and myasthenia gravis. In ALS, fatigue may include a deep sense of exhaustion that can affect quality of life.
In myasthenia gravis, muscle weakness usually worsens with activity, making everyday tasks more difficult. People with myasthenia gravis may notice that fatigue improves with rest.
Neurologists (doctors who treat diseases of the brain, spinal cord, and nerves) use similar tests to diagnose myasthenia gravis and ALS. These are called electrodiagnostic tests.
In ALS, needle electromyography (EMG) can detect signs of dysfunction in lower motor neurons located in the brainstem and spinal cord. In myasthenia gravis, repetitive nerve stimulation and single-fiber EMG can pick up on electrical activity between nerves and muscles, showing how nerves and muscles communicate.
These tests can help determine how the nervous system is working and differentiate between the two conditions.
There’s no cure for ALS or myasthenia gravis. But treatments are available, especially for myasthenia gravis, where medications can significantly improve symptoms.
Research is ongoing to find better treatments and potential cures for both conditions. Regular follow-ups with a neurology provider are crucial for managing both disorders and maintaining quality of life.
Although ALS and myasthenia gravis share some similarities, they’re very different. They have distinct causes, symptoms, patterns, and treatment approaches.
ALS damages motor neurons in the brain and spinal cord, which control movement. Most of the time, doctors don’t know exactly what causes it. Certain factors might raise the risk of developing ALS, such as:
Myasthenia gravis is an autoimmune disorder. The immune system makes antibodies that attack different proteins at the neuromuscular junction — the connection point where nerves signal muscles to move.
These antibodies target AChR, MuSK, LRP4, or other proteins involved in nerve-to-muscle signaling. This can prevent proper muscle contraction, leading to weakness. Genetic factors may also play a role in myasthenia gravis.

In ALS, muscle weakness often begins in the limbs and progresses steadily without improvement. The weakness causes the muscles to waste away, eventually leading to paralysis.
Myasthenia gravis muscle weakness tends to fluctuate. It usually starts with the eye muscles, causing drooping eyelids and double vision. People living with myasthenia gravis may also have weakness in their arms, legs, and neck.
Unlike ALS, myasthenia gravis doesn’t cause muscle atrophy (muscle loss) directly. But factors like lack of muscle use may contribute to muscle loss. Myasthenia gravis symptoms also worsen with activity but improve with rest.
Fasciculations (involuntary muscle twitches) are a common symptom of ALS. These twitches can happen anywhere in the body. They’re not usually painful, but may disrupt sleep.
In contrast, muscle twitching isn’t a typical symptom of myasthenia gravis. In rare cases, involuntary twitches may occur with MuSK-positive myasthenia gravis.
Many people with myasthenia gravis have abnormalities in their thymus, a gland that helps train and develop the immune system. Thymic follicular hyperplasia (an increase in immune cells in the thymus) occurs in around 75 percent of people with myasthenia gravis. Thymomas (thymus tumors) are less common, affecting about 15 percent of people with myasthenia gravis.
Problems with the thymus may contribute to the immune system mistakenly attacking healthy tissue in myasthenia gravis. ALS, however, isn’t associated with the thymus.
Doctors can help diagnose myasthenia gravis using blood tests that detect anti-AChR or MuSK antibodies. However, some people with myasthenia gravis don’t test positive for these antibodies. In these cases, additional tests may be needed to diagnose myasthenia gravis.
In contrast, there isn’t a single type of blood test that can diagnose ALS. Instead, doctors use blood tests to rule out conditions similar to ALS or identify genetic mutations linked to the disease. Together with physical exams and nerve and muscle tests, these findings can support a diagnosis of ALS and help determine the best treatment interventions.
ALS treatments focus on slowing disease progression and managing symptoms. They include:
Myasthenia gravis treatments aim to improve muscle function and suppress the immune system. They include:
Symptoms of ALS progress steadily and don’t improve. Key signs include progressive muscle weakness (usually starting in the limbs), muscle atrophy, and eventual paralysis.
In myasthenia gravis, symptoms can fluctuate day to day. Periods of worsening symptoms may be followed by periods of improvement.
ALS is a progressive disease with no cure. After diagnosis, most people live another two to five years, but some live much longer.
With proper treatment, myasthenia gravis typically doesn’t reduce life expectancy. Most people with myasthenia gravis can lead full lives with managed symptoms.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
My husband story is very similar to your beginning. He started having speech problems in 2022 progressively gotten worse. He can talk but hard to understand most of the time. Better in the morning… read more
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.